In the new normal of COVID-19, the debate about immediately sequential bilateral cataract surgery has come back in the limelight.Is it necessary? Is it possible? Is it risk-benefit profitable? Do we have a real advantage in performing it? These are som…
Dr Christopher Rapuano comments on a recent study showing significant measurement variability of the Pentacam, and what it may mean for treating progression. Medscape Ophthalmology
日本大阪–(BUSINESS WIRE)–(美国商业资讯)–武田药品工业株式会社(TSE:4502/NYSE:TAK)今天宣布，Novavax的COVID-19候选疫苗(TAK-019)在日本的1/2期免疫原性和安全性研究完成首例受试者接种。本月早些时候，武田完成了Moderna的COVID-19候选疫苗(TAK-919)在日本的1/2期免疫原性和安全性研究入组。 武田全球疫苗业务部总裁Rajeev Venkayya, M.D.表示：“在大流行初期，我们决定与其他公司合作，发挥我们丰富的疫苗经…
日本大阪–(BUSINESS WIRE)–(美國商業資訊)–武田藥品工業株式會社(TSE:4502/NYSE:TAK)今天宣布，Novavax的COVID-19候選疫苗(TAK-019)在日本的1/2期免疫原性和安全性研究完成首例受試者接種。本月稍早，武田完成了Moderna的COVID-19候選疫苗(TAK-919)在日本的1/2期免疫原性和安全性研究入組。 武田全球疫苗業務部總裁Rajeev Venkayya, M.D.表示：「在大流行初期，我們決定與其他公司合作，發揮我們豐富的疫苗經驗和…
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced finan…
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that …